Skip to main content

Table 2 Relationship between advanced NSCLC prognosis and GPS and serum tumor markers in 138 patients

From: The relationship between glasgow prognostic score and serum tumor markers in patients with advanced non-small cell lung cancer

Characteristics Disease-Free survival Overall survival
Univariate Multivariate Univariate Multivariate
HR(95% CI) P HR(95% CI) P HR(95% CI) P HR(95% CI) P
GPS         
0 1 0.01* 1 0.03* 1 0.02* 1 0.02*
1 0.7(0.4–0.9)   0.8(0.5–0.9)   0.8(0.5–0.9)   0.8(0.4–0.9)  
2 0.5(0.2–0.8)   0.6(0.2–0.8)   0.5(0.3–0.8)   0.5(0.2–0.9)  
CYFRA21-1 (>3.3 ng/ml) 0.6(0.5–0.9) 0.03* 0.7(0.5–1.0) 0.08 0.7(0.3–0.9) 0.04* 0.8(0.5–1.0) 0.07
CEA (>5 ng/ml) 0.7(0.4–1.1) 0.13 0.7(0.5–1.2) 0.17 0.8(0.5–1.1) 0.19 0.8(0.6–1.3) 0.19
TPS (>80 U/l) 0.7(0.5–0.9) 0.04* 0.7(0.5–1.1) 0.12 0.8(0.5–1.0) 0.05 0.8(0.4–1.1) 0.13
  1. *P < 0.05.